No Data
Frontage Holdings to Review Annual Results and Dividend Proposal
FRONTAGE (01521.HK) will hold a Board of Directors meeting on March 27 to approve the annual performance.
Gelonghui, March 14 - FRONTAGE (01521.HK) announced that the Board of Directors will hold a meeting on March 27, 2025, to approve the release of the annual performance announcement for the year ending December 31, 2024, and to consider the recommendation of a final dividend (if any).
FRONTAGE: DATE OF BOARD MEETING
Trending Industry Today: WUXI BIO Leads Gains In CRO Stocks
Hong Kong stocks move | CRO Concept stocks plunged sharply in the morning as the USA plans to tighten investment restriction policies. Institutions say there is a risk of short-term impact on market sentiment.
CRO Concept stocks plummeted in the morning; as of the time of writing, WUXI APPTEC (02359) is down 9%, trading at 63.7 Hong Kong dollars; FRONTAGE (01521) is down 6.99%, trading at 1.33 Hong Kong dollars; PHARMARON (03759) is down 5.83%, trading at 18.1 Hong Kong dollars; TIGERMED (03347) is down 5.7%, trading at 36.4 Hong Kong dollars.
Trending Industry Today: WUXI BIO Leads Losses In CRO Stocks
Despite Hitting HK$1.67, Frontage Holdings Insiders Still Sold Too Soon
